Skip to content

Clinical trials

Observational Metabolic Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Observational Country / region: United Kingdom Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20132
20181
20201
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status3
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.1
Calcilytix Therapeutics, Inc., a BridgeBio company1
HemoShear Therapeutics1
King's College Hospital NHS Trust1
Nottingham University Hospitals NHS Trust1
Oxford University Hospitals NHS Trust1
The Leeds Teaching Hospitals NHS Trust1
University of Oxford1
iECURE, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases9
Genetic Diseases, Inborn3
Metabolism, Inborn Errors3
Cardiovascular Diseases2
Amino Acid Metabolism, Inborn Errors1
Autoimmune Diseases1
Brain Diseases1
Brain Diseases, Metabolic1
Brain Diseases, Metabolic, Inborn1
Calcium Metabolism Disorders1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.